RegeneRx Biopharmaceuticals (OTCMKTS:RGRX) Stock Passes Below 50 Day Moving Average of $0.17

RegeneRx Biopharmaceuticals, Inc. (OTCMKTS:RGRXGet Rating) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.17 and traded as low as $0.14. RegeneRx Biopharmaceuticals shares last traded at $0.14, with a volume of 10,709 shares.

RegeneRx Biopharmaceuticals Stock Down 6.5 %

The company’s fifty day simple moving average is $0.17 and its 200-day simple moving average is $0.19.

About RegeneRx Biopharmaceuticals

(Get Rating)

RegeneRx Biopharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue.

Featured Articles

Want More Great Investing Ideas?

Receive News & Ratings for RegeneRx Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RegeneRx Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.